V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240002486 | 240011441 | null | 96.8 | Curative (C) | 2021-05-29 | 2022-03-16 | null | 02 | N | FLAIR TRIAL | 101706950 |
| 240002487 | 240011442 | 1.6 | 76.3 | null | 2018-10-06 | 2018-10-06 | Venetoclax | N | null | CML IMATINIB | 100475949 |
| 240002489 | 240011443 | 1.5 | 80.4 | 03 | 2021-07-19 | 2021-07-21 | ATG + Busulfan + Fludarabine | 02 | null | IBRUTINIB | 101869442 |
| 240002530 | 240011444 | 1.84 | 116.7 | 03 | 2016-11-08 | 2017-02-09 | GEMCITABINE | 02 | null | PACLITAXEL | 101456655 |
| 240002577 | 240011448 | 1.63 | 88 | Curative (C) | 2021-07-07 | 2021-08-11 | AML MyeChild 01 Triple IT | 02 | null | ALL UKALL2011 MAINTENANCE | 101309020 |
| 240002583 | 240011449 | 0 | 138.9 | 03 | 2021-10-24 | 2021-10-25 | ALL UKALL2011 Maintenance A1 | 02 | null | DASATINIB | 100560456 |
| 240002597 | 240011450 | 0.9 | 14.8 | null | 2018-02-07 | 2018-12-14 | CYTARABINE + DAUNORUBICIN + Gemtuzumab Ozogamicin | 2 | N | AML MYECHILD 01 HD ARAC | 101029319 |
| 240002610 | 240011451 | 1.63 | 86 | Curative (C) | 2017-03-17 | 2020-01-05 | AMADEUS TRIAL | 02 | N | CVP R | 100238819 |
| 240002619 | 240011452 | 1.75 | 17 | null | 2019-09-15 | 2019-09-15 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | METHOTREXATE + PEGASPARAGINASE | 101456528 |
| 240002620 | 240011453 | 1.85 | 68.8 | Curative (C) | 2021-03-19 | 2021-03-26 | Triple / Double Intrathecal Therapy + hydrocortisone | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + VINCRISTINE | 100852396 |
| 240002631 | 240011454 | 1.73 | 91.2 | Disease modification (D) | 2019-07-03 | 2019-07-09 | Triple / Double Intrathecal Therapy + hydrocortisone | 01 | null | CYCLOPHOSPHAMIDE + FLUDARABINE | 100610839 |
| 240002730 | 240011460 | 1.75 | 75.5 | Curative (C) | 2020-11-14 | 2021-01-21 | Rituximab + Venetoclax | N | null | RUXOLITINIB | 100332081 |
| 240002815 | 240011463 | 1.68 | 16.7 | null | 2020-01-28 | 2020-03-17 | null | 02 | null | IMATINIB | 100137843 |
| 240002839 | 240011466 | 1.86 | 30.55 | null | 2019-03-01 | 2019-03-04 | RUXOLITINIB | 02 | N | INTERFERON ALFA | 100264509 |
| 240000533 | 240011469 | 0 | 27.4 | Curative (C) | 2020-02-16 | 2020-02-16 | null | 02 | N | DABRAFENIB | 100823555 |
| 240000626 | 240011470 | null | null | null | 2017-12-12 | 2017-12-17 | Trial Unspecified | 02 | null | CYCLOPHOSPHAMIDE + CYTARABINE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101019381 |
| 240001015 | 240011471 | 1.9 | 84.1 | Curative (C) | 2017-08-17 | 2017-08-24 | Cyclophosphamide oral | 02 | null | IBRUTINIB | 101156464 |
| 240000791 | 240011506 | null | null | null | null | 2019-10-29 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101496728 |
| 240000857 | 240011520 | null | null | null | null | 2019-03-01 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100063172 |
| 240000914 | 240011537 | null | null | null | null | 2016-06-17 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100619343 |
| 240000941 | 240011545 | 1.59 | 99.8 | null | null | 2018-04-20 | null | null | null | AML19 TRIAL | 100851429 |
| 240000948 | 240011547 | null | null | Curative (C) | null | 2020-02-29 | null | null | N | CHOP R | 101636865 |
| 240000950 | 240011548 | 1.68 | 0 | null | null | 2020-06-05 | null | 02 | N | AML18 TRIAL | 101742824 |
| 240000951 | 240011549 | 0 | 90.9 | null | null | 2019-08-23 | null | 02 | null | HYDROXYCARBAMIDE | 101525420 |
| 240000958 | 240011552 | 1.75 | 88.6 | 03 | null | 2018-10-16 | null | N | N | RITUXIMAB | 101507308 |
| 240000960 | 240011553 | 1.59 | 71.2 | 03 | 2017-05-23 | 2017-05-25 | Hydroxycarbamide | 02 | N | HYDROXYCARBAMIDE | 101321769 |
| 240000965 | 240011555 | 0 | 102.85 | null | 2022-04-07 | 2022-04-07 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 101400994 |
| 240000966 | 240011556 | 1.68 | 72 | Curative (C) | null | 2022-03-27 | null | null | null | RITUXIMAB | 101666472 |
| 240000982 | 240011560 | 0 | 59.1 | null | null | 2018-06-28 | null | null | null | METHOTREXATE | 100104477 |
| 240000984 | 240011561 | 0 | 93 | null | null | 2021-02-19 | null | 02 | null | AZACITIDINE | 101342003 |
| 240000988 | 240011562 | 1.69 | 0 | null | null | 2019-11-23 | null | null | null | RITUXIMAB | 100098412 |
| 240000993 | 240011564 | 1.91 | 102.9 | null | null | 2019-08-13 | null | 01 | null | AZACITIDINE | 101389629 |
| 240000996 | 240011565 | 1.82 | 21.6 | Palliative (P) | 2019-04-28 | 2019-07-08 | Rituximab | 02 | N | RITUXIMAB | 101352952 |
| 240000997 | 240011566 | 1.62 | 52 | null | null | 2021-08-16 | null | null | null | AZACITIDINE | 101737204 |
| 240000998 | 240011567 | 1.68 | 75 | null | null | 2016-04-21 | null | 02 | null | AZACITIDINE | 101189260 |
| 240001017 | 240011568 | null | null | null | 2022-05-22 | 2022-05-24 | Hydroxycarbamide | 02 | N | HYDROXYCARBAMIDE | 101586177 |
| 240001091 | 240011572 | 1.61 | 66.85 | null | 2020-07-01 | 2020-07-03 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 100020934 |
| 240001095 | 240011573 | null | null | Palliative (P) | null | 2020-03-17 | null | 01 | null | RITUXIMAB | 101404275 |
| 240001105 | 240011574 | 1.69 | 32.6 | Curative (C) | null | 2020-12-20 | null | 02 | N | METHOTREXATE | 100233112 |
| 240001153 | 240011576 | 1.6 | 65.8 | Curative (C) | null | 2021-01-12 | null | N | N | CYTARABINE | 100890892 |
| 240001201 | 240011578 | 1.59 | 74.2 | null | null | 2020-12-17 | null | null | null | CHOP R | 101635703 |
| 240001255 | 240011581 | 0 | 72 | Curative (C) | 2018-03-27 | 2018-03-28 | Hydroxycarbamide | N | null | HYDROXYCARBAMIDE | 100575047 |
| 240001304 | 240011583 | 1.77 | 125.5 | null | 2019-08-18 | 2019-09-15 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 100407630 |
| 240001372 | 240011586 | 1.65 | 0 | null | null | 2019-06-19 | null | 02 | N | BENDAMUSTINE + RITUXIMAB | 100692052 |
| 240001405 | 240011587 | 1.73 | 74 | 03 | 2022-02-08 | 2022-02-08 | AML 18 TRIAL | null | N | CHOP R | 100762947 |
| 240001430 | 240011588 | 1.82 | null | null | 2020-03-28 | 2020-03-28 | AML 18 TRIAL | null | null | AZACITIDINE | 101367622 |
| 240001436 | 240011589 | null | 69 | Adjuvant (A) | 2021-01-18 | 2021-01-21 | Hydroxycarbamide | 02 | N | HYDROXYCARBAMIDE | 100913396 |
| 240001526 | 240011590 | 0 | 60.7 | 03 | 2020-08-02 | 2020-08-12 | Hydroxycarbamide | 02 | N | HYDROXYCARBAMIDE | 100399158 |
| 240001539 | 240011591 | 1.76 | 74 | null | null | 2016-09-13 | null | 02 | N | HYDROXYCARBAMIDE | 101163127 |
| 240001749 | 240011595 | 1.77 | 61 | Adjuvant (A) | null | 2021-12-08 | null | null | N | HYDROXYCARBAMIDE | 101345435 |